APO Research
Talk to an analyst

APO RESEARCH · REPORT

Compounded Topical Drug

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Compounded Topical Drug Market Outlook and Growth Opportunities 2026

29 December 2025207 pages

Choose your research edition.

Industry ResearchCompounded Topical Drug Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Compounded Topical Drug Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Compounded Topical Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Compounded Topical Drug Market Outlook and Growth Opportunities 2026207 pages · $4,250 USDMarket Analysis & ForecastGlobal Compounded Topical Drug Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

The global Compounded Topical Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Compounded Topical Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Compounded Topical Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Compounded Topical Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Compounded Topical Drug market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Compounded Topical Drug market include Triangle Compounding Pharmacy, QuVa Pharma, PharMEDium Services, Pharmaca Integrative Pharmacy, Perrigo Company plc, PCCA (Professional Compounding Centers of America), Nephron Pharmaceuticals Corporation, Medisca and Lorraine’s Pharmacy, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Compounded Topical Drug market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Compounded Topical Drug and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Compounded Topical Drug revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Compounded Topical Drug market.

Compounded Topical Drug Segment by Company

Triangle Compounding Pharmacy

QuVa Pharma

PharMEDium Services

Pharmaca Integrative Pharmacy

Perrigo Company plc

PCCA (Professional Compounding Centers of America)

Nephron Pharmaceuticals Corporation

Medisca

Lorraine’s Pharmacy

Institutional Pharmacy Solutions

Fresenius Kabi

Fagron

Custom Scripts Pharmacy

Central Admixture Pharmacy Services (CAPS)

CareFirst Specialty Pharmacy

Cantrell Drug Company

B. Braun Melsungen AG Company

Avella Specialty Pharmacy

Atlas Pharmaceuticals

Compounded Topical Drug Segment by Type

Ointments

Lotions

Cream

Gels

Compounded Topical Drug Segment by Application

Hospitals

Retail Pharmacy

Other

Compounded Topical Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Compounded Topical Drug status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Compounded Topical Drug key companies, revenue, market share, and recent developments.

3. To split the Compounded Topical Drug breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Compounded Topical Drug market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Compounded Topical Drug significant trends, drivers, influence factors in global and regions.

6. To analyze Compounded Topical Drug competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Compounded Topical Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Compounded Topical Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Compounded Topical Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Compounded Topical Drug industry.

Chapter 3: Detailed analysis of Compounded Topical Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Compounded Topical Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Compounded Topical Drug in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Compounded Topical Drug Industry Trends Table 2. Compounded Topical Drug Industry Drivers Table 3. Compounded Topical Drug Industry Opportunities and Challenges Table 4. Compounded Topical Drug Industry Restraints Table 5. Global Compounded Topical Drug Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Compounded Topical Drug Revenue Share by Company (2021-2026) Table 7. Global Compounded Topical Drug Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Compounded Topical Drug Key Company Manufacturing Base & Headquarters Table 9. Global Compounded Topical Drug Company, Product Type & Application Table 10. Global Compounded Topical Drug Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Compounded Topical Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Ointments Table 15. Significant Companies of Lotions Table 16. Significant Companies of Cream Table 17. Significant Companies of Gels Table 18. Global Compounded Topical Drug Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Compounded Topical Drug Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Compounded Topical Drug Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Compounded Topical Drug Sales Value Share by Type (2021-2026) Table 22. Global Compounded Topical Drug Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Hospitals Table 24. Significant Companies of Retail Pharmacy Table 25. Significant Companies of Other Table 26. Global Compounded Topical Drug Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Compounded Topical Drug Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Compounded Topical Drug Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Compounded Topical Drug Sales Value Share by Application (2021-2026) Table 30. Global Compounded Topical Drug Sales Value Share by Application (2027-2032) Table 31. Global Compounded Topical Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Compounded Topical Drug Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Compounded Topical Drug Sales Value Share by Region (2021-2026) Table 34. Global Compounded Topical Drug Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Compounded Topical Drug Sales Value Share by Region (2027-2032) Table 36. Global Compounded Topical Drug Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Compounded Topical Drug Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Compounded Topical Drug Sales Value Market Share by Country (2021-2026) Table 39. Global Compounded Topical Drug Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Compounded Topical Drug Sales Value Market Share by Country (2027-2032) Table 41. Triangle Compounding Pharmacy Company Information Table 42. Triangle Compounding Pharmacy Business Overview Table 43. Triangle Compounding Pharmacy Compounded Topical Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. Triangle Compounding Pharmacy Compounded Topical Drug Product Portfolio Table 45. Triangle Compounding Pharmacy Recent Development Table 46. QuVa Pharma Company Information Table 47. QuVa Pharma Business Overview Table 48. QuVa Pharma Compounded Topical Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. QuVa Pharma Compounded Topical Drug Product Portfolio Table 50. QuVa Pharma Recent Development Table 51. PharMEDium Services Company Information Table 52. PharMEDium Services Business Overview Table 53. PharMEDium Services Compounded Topical Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. PharMEDium Services Compounded Topical Drug Product Portfolio Table 55. PharMEDium Services Recent Development Table 56. Pharmaca Integrative Pharmacy Company Information Table 57. Pharmaca Integrative Pharmacy Business Overview Table 58. Pharmaca Integrative Pharmacy Compounded Topical Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Pharmaca Integrative Pharmacy Compounded Topical Drug Product Portfolio Table 60. Pharmaca Integrative Pharmacy Recent Development Table 61. Perrigo Company plc Company Information Table 62. Perrigo Company plc Business Overview Table 63. Perrigo Company plc Compounded Topical Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Perrigo Company plc Compounded Topical Drug Product Portfolio Table 65. Perrigo Company plc Recent Development Table 66. PCCA (Professional Compounding Centers of America) Company Information Table 67. PCCA (Professional Compounding Centers of America) Business Overview Table 68. PCCA (Professional Compounding Centers of America) Compounded Topical Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. PCCA (Professional Compounding Centers of America) Compounded Topical Drug Product Portfolio Table 70. PCCA (Professional Compounding Centers of America) Recent Development Table 71. Nephron Pharmaceuticals Corporation Company Information Table 72. Nephron Pharmaceuticals Corporation Business Overview Table 73. Nephron Pharmaceuticals Corporation Compounded Topical Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Nephron Pharmaceuticals Corporation Compounded Topical Drug Product Portfolio Table 75. Nephron Pharmaceuticals Corporation Recent Development Table 76. Medisca Company Information Table 77. Medisca Business Overview Table 78. Medisca Compounded Topical Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Medisca Compounded Topical Drug Product Portfolio Table 80. Medisca Recent Development Table 81. Lorraine’s Pharmacy Company Information Table 82. Lorraine’s Pharmacy Business Overview Table 83. Lorraine’s Pharmacy Compounded Topical Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Lorraine’s Pharmacy Compounded Topical Drug Product Portfolio Table 85. Lorraine’s Pharmacy Recent Development Table 86. Institutional Pharmacy Solutions Company Information Table 87. Institutional Pharmacy Solutions Business Overview Table 88. Institutional Pharmacy Solutions Compounded Topical Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Institutional Pharmacy Solutions Compounded Topical Drug Product Portfolio Table 90. Institutional Pharmacy Solutions Recent Development Table 91. Fresenius Kabi Company Information Table 92. Fresenius Kabi Business Overview Table 93. Fresenius Kabi Compounded Topical Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Fresenius Kabi Compounded Topical Drug Product Portfolio Table 95. Fresenius Kabi Recent Development Table 96. Fagron Company Information Table 97. Fagron Business Overview Table 98. Fagron Compounded Topical Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Fagron Compounded Topical Drug Product Portfolio Table 100. Fagron Recent Development Table 101. Custom Scripts Pharmacy Company Information Table 102. Custom Scripts Pharmacy Business Overview Table 103. Custom Scripts Pharmacy Compounded Topical Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Custom Scripts Pharmacy Compounded Topical Drug Product Portfolio Table 105. Custom Scripts Pharmacy Recent Development Table 106. Central Admixture Pharmacy Services (CAPS) Company Information Table 107. Central Admixture Pharmacy Services (CAPS) Business Overview Table 108. Central Admixture Pharmacy Services (CAPS) Compounded Topical Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Central Admixture Pharmacy Services (CAPS) Compounded Topical Drug Product Portfolio Table 110. Central Admixture Pharmacy Services (CAPS) Recent Development Table 111. CareFirst Specialty Pharmacy Company Information Table 112. CareFirst Specialty Pharmacy Business Overview Table 113. CareFirst Specialty Pharmacy Compounded Topical Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. CareFirst Specialty Pharmacy Compounded Topical Drug Product Portfolio Table 115. CareFirst Specialty Pharmacy Recent Development Table 116. Cantrell Drug Company Company Information Table 117. Cantrell Drug Company Business Overview Table 118. Cantrell Drug Company Compounded Topical Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Cantrell Drug Company Compounded Topical Drug Product Portfolio Table 120. Cantrell Drug Company Recent Development Table 121. B. Braun Melsungen AG Company Company Information Table 122. B. Braun Melsungen AG Company Business Overview Table 123. B. Braun Melsungen AG Company Compounded Topical Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. B. Braun Melsungen AG Company Compounded Topical Drug Product Portfolio Table 125. B. Braun Melsungen AG Company Recent Development Table 126. Avella Specialty Pharmacy Company Information Table 127. Avella Specialty Pharmacy Business Overview Table 128. Avella Specialty Pharmacy Compounded Topical Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Avella Specialty Pharmacy Compounded Topical Drug Product Portfolio Table 130. Avella Specialty Pharmacy Recent Development Table 131. Atlas Pharmaceuticals Company Information Table 132. Atlas Pharmaceuticals Business Overview Table 133. Atlas Pharmaceuticals Compounded Topical Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. Atlas Pharmaceuticals Compounded Topical Drug Product Portfolio Table 135. Atlas Pharmaceuticals Recent Development Table 136. Research Programs/Design for This Report Table 137. Authors List of This Report Table 138. Secondary Sources Table 139. Primary Sources List of Figures Figure 1. Compounded Topical Drug Product Image Figure 2. Global Compounded Topical Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Compounded Topical Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Compounded Topical Drug Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Ointments Image Figure 8. Lotions Image Figure 9. Cream Image Figure 10. Gels Image Figure 11. Global Compounded Topical Drug Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Compounded Topical Drug Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Compounded Topical Drug Sales Value Share by Type (2021-2032) Figure 14. Hospitals Image Figure 15. Retail Pharmacy Image Figure 16. Other Image Figure 17. Global Compounded Topical Drug Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Compounded Topical Drug Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Compounded Topical Drug Sales Value Share by Application (2021-2032) Figure 20. Global Compounded Topical Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Compounded Topical Drug Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Compounded Topical Drug Sales Value (2021-2032) & (US$ Million) Figure 23. North America Compounded Topical Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Compounded Topical Drug Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Compounded Topical Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Compounded Topical Drug Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Compounded Topical Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Compounded Topical Drug Sales Value (2021-2032) & (US$ Million) Figure 29. South America Compounded Topical Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Compounded Topical Drug Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Compounded Topical Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Compounded Topical Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Compounded Topical Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Compounded Topical Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Compounded Topical Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Compounded Topical Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Compounded Topical Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Compounded Topical Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Compounded Topical Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Compounded Topical Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Compounded Topical Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Compounded Topical Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Compounded Topical Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Compounded Topical Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Compounded Topical Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Compounded Topical Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Compounded Topical Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Compounded Topical Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Compounded Topical Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Compounded Topical Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Compounded Topical Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Compounded Topical Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Compounded Topical Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Compounded Topical Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Compounded Topical Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Compounded Topical Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Compounded Topical Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Compounded Topical Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Compounded Topical Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Compounded Topical Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Compounded Topical Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Compounded Topical Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Compounded Topical Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Compounded Topical Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Compounded Topical Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Compounded Topical Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Compounded Topical Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Compounded Topical Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Compounded Topical Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Compounded Topical Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Compounded Topical Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Compounded Topical Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Compounded Topical Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Compounded Topical Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Compounded Topical Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Compounded Topical Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Compounded Topical Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Compounded Topical Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Compounded Topical Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Compounded Topical Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Compounded Topical Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Compounded Topical Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Compounded Topical Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Compounded Topical Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Compounded Topical Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Compounded Topical Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Compounded Topical Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Compounded Topical Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Compounded Topical Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Compounded Topical Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Compounded Topical Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Compounded Topical Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Compounded Topical Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Compounded Topical Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Compounded Topical Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Compounded Topical Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Compounded Topical Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Compounded Topical Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Compounded Topical Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Compounded Topical Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Compounded Topical Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Compounded Topical Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Compounded Topical Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Compounded Topical Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Compounded Topical Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Compounded Topical Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Compounded Topical Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Compounded Topical Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Compounded Topical Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Compounded Topical Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Compounded Topical Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Compounded Topical Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Compounded Topical Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Compounded Topical Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Compounded Topical Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Ointments
  • Lotions
  • Cream
  • Gels
Applications
  • Hospitals
  • Retail Pharmacy
  • Other
Companies covered
  • Triangle Compounding Pharmacy
  • QuVa Pharma
  • PharMEDium Services
  • Pharmaca Integrative Pharmacy
  • Perrigo Company plc
  • PCCA (Professional Compounding Centers of America)
  • Nephron Pharmaceuticals Corporation
  • Medisca
  • Lorraine’s Pharmacy
  • Institutional Pharmacy Solutions
  • Fresenius Kabi
  • Fagron
  • Custom Scripts Pharmacy
  • Central Admixture Pharmacy Services (CAPS)
  • CareFirst Specialty Pharmacy
  • Cantrell Drug Company
  • B. Braun Melsungen AG Company
  • Avella Specialty Pharmacy
  • Atlas Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Compounded Topical Drug Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Compounded Topical Drug Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Compounded Topical Drug Market Dynamics
  1. 2.1 Compounded Topical Drug Industry Trends
  2. 2.2 Compounded Topical Drug Industry Drivers
  3. 2.3 Compounded Topical Drug Industry Opportunities and Challenges
  4. 2.4 Compounded Topical Drug Industry Restraints
3 Compounded Topical Drug Market by Company
  1. 3.1 Global Compounded Topical Drug Company Revenue Ranking in 2025
  2. 3.2 Global Compounded Topical Drug Revenue by Company (2021-2026)
  3. 3.3 Global Compounded Topical Drug Company Ranking (2024-2026)
  4. 3.4 Global Compounded Topical Drug Company Manufacturing Base and Headquarters
  5. 3.5 Global Compounded Topical Drug Company Product Type and Application
  6. 3.6 Global Compounded Topical Drug Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Compounded Topical Drug Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Compounded Topical Drug Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Compounded Topical Drug Market by Type
  1. 4.1 Compounded Topical Drug Type Introduction
  2. 4.1.1 Ointments
  3. 4.1.2 Lotions
  4. 4.1.3 Cream
  5. 4.1.4 Gels
  6. 4.2 Global Compounded Topical Drug Sales Value by Type
  7. 4.2.1 Global Compounded Topical Drug Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Compounded Topical Drug Sales Value by Type (2021-2032)
  9. 4.2.3 Global Compounded Topical Drug Sales Value Share by Type (2021-2032)
5 Compounded Topical Drug Market by Application
  1. 5.1 Compounded Topical Drug Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Retail Pharmacy
  4. 5.1.3 Other
  5. 5.2 Global Compounded Topical Drug Sales Value by Application
  6. 5.2.1 Global Compounded Topical Drug Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Compounded Topical Drug Sales Value by Application (2021-2032)
  8. 5.2.3 Global Compounded Topical Drug Sales Value Share by Application (2021-2032)
6 Compounded Topical Drug Regional Value Analysis
  1. 6.1 Global Compounded Topical Drug Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Compounded Topical Drug Sales Value by Region (2021-2032)
  3. 6.2.1 Global Compounded Topical Drug Sales Value by Region: 2021-2026
  4. 6.2.2 Global Compounded Topical Drug Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Compounded Topical Drug Sales Value (2021-2032)
  7. 6.3.2 North America Compounded Topical Drug Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Compounded Topical Drug Sales Value (2021-2032)
  10. 6.4.2 Europe Compounded Topical Drug Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Compounded Topical Drug Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Compounded Topical Drug Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Compounded Topical Drug Sales Value (2021-2032)
  16. 6.6.2 South America Compounded Topical Drug Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Compounded Topical Drug Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Compounded Topical Drug Sales Value Share by Country, 2025 VS 2032
7 Compounded Topical Drug Country-level Value Analysis
  1. 7.1 Global Compounded Topical Drug Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Compounded Topical Drug Sales Value by Country (2021-2032)
  3. 7.2.1 Global Compounded Topical Drug Sales Value by Country (2021-2026)
  4. 7.2.2 Global Compounded Topical Drug Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Compounded Topical Drug Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Compounded Topical Drug Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Compounded Topical Drug Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Compounded Topical Drug Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Compounded Topical Drug Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Compounded Topical Drug Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Compounded Topical Drug Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Compounded Topical Drug Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Compounded Topical Drug Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Compounded Topical Drug Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Compounded Topical Drug Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Compounded Topical Drug Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Compounded Topical Drug Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Compounded Topical Drug Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Compounded Topical Drug Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Compounded Topical Drug Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Compounded Topical Drug Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Compounded Topical Drug Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Compounded Topical Drug Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Compounded Topical Drug Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Compounded Topical Drug Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Compounded Topical Drug Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Compounded Topical Drug Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Compounded Topical Drug Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Compounded Topical Drug Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Compounded Topical Drug Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Compounded Topical Drug Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Compounded Topical Drug Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Compounded Topical Drug Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Compounded Topical Drug Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Compounded Topical Drug Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Compounded Topical Drug Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Compounded Topical Drug Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Compounded Topical Drug Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Compounded Topical Drug Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Compounded Topical Drug Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Compounded Topical Drug Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Compounded Topical Drug Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Compounded Topical Drug Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Compounded Topical Drug Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Compounded Topical Drug Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Compounded Topical Drug Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Compounded Topical Drug Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Compounded Topical Drug Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Compounded Topical Drug Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Compounded Topical Drug Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Compounded Topical Drug Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Compounded Topical Drug Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Compounded Topical Drug Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Compounded Topical Drug Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Compounded Topical Drug Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Compounded Topical Drug Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Compounded Topical Drug Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Compounded Topical Drug Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Compounded Topical Drug Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Compounded Topical Drug Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Compounded Topical Drug Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Compounded Topical Drug Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Compounded Topical Drug Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Compounded Topical Drug Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Compounded Topical Drug Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Compounded Topical Drug Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Compounded Topical Drug Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Compounded Topical Drug Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Compounded Topical Drug Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Compounded Topical Drug Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Compounded Topical Drug Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Compounded Topical Drug Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Compounded Topical Drug Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Compounded Topical Drug Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Compounded Topical Drug Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Compounded Topical Drug Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Compounded Topical Drug Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Compounded Topical Drug Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Compounded Topical Drug Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Compounded Topical Drug Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Compounded Topical Drug Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Compounded Topical Drug Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Compounded Topical Drug Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Compounded Topical Drug Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Compounded Topical Drug Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Compounded Topical Drug Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Compounded Topical Drug Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Compounded Topical Drug Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Triangle Compounding Pharmacy
  2. 8.1.1 Triangle Compounding Pharmacy Company Information
  3. 8.1.2 Triangle Compounding Pharmacy Business Overview
  4. 8.1.3 Triangle Compounding Pharmacy Compounded Topical Drug Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Triangle Compounding Pharmacy Compounded Topical Drug Product Portfolio
  6. 8.1.5 Triangle Compounding Pharmacy Recent Developments
  7. 8.2 QuVa Pharma
  8. 8.2.1 QuVa Pharma Company Information
  9. 8.2.2 QuVa Pharma Business Overview
  10. 8.2.3 QuVa Pharma Compounded Topical Drug Revenue and Gross Margin (2021-2026)
  11. 8.2.4 QuVa Pharma Compounded Topical Drug Product Portfolio
  12. 8.2.5 QuVa Pharma Recent Developments
  13. 8.3 PharMEDium Services
  14. 8.3.1 PharMEDium Services Company Information
  15. 8.3.2 PharMEDium Services Business Overview
  16. 8.3.3 PharMEDium Services Compounded Topical Drug Revenue and Gross Margin (2021-2026)
  17. 8.3.4 PharMEDium Services Compounded Topical Drug Product Portfolio
  18. 8.3.5 PharMEDium Services Recent Developments
  19. 8.4 Pharmaca Integrative Pharmacy
  20. 8.4.1 Pharmaca Integrative Pharmacy Company Information
  21. 8.4.2 Pharmaca Integrative Pharmacy Business Overview
  22. 8.4.3 Pharmaca Integrative Pharmacy Compounded Topical Drug Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Pharmaca Integrative Pharmacy Compounded Topical Drug Product Portfolio
  24. 8.4.5 Pharmaca Integrative Pharmacy Recent Developments
  25. 8.5 Perrigo Company plc
  26. 8.5.1 Perrigo Company plc Company Information
  27. 8.5.2 Perrigo Company plc Business Overview
  28. 8.5.3 Perrigo Company plc Compounded Topical Drug Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Perrigo Company plc Compounded Topical Drug Product Portfolio
  30. 8.5.5 Perrigo Company plc Recent Developments
  31. 8.6 PCCA (Professional Compounding Centers of America)
  32. 8.6.1 PCCA (Professional Compounding Centers of America) Company Information
  33. 8.6.2 PCCA (Professional Compounding Centers of America) Business Overview
  34. 8.6.3 PCCA (Professional Compounding Centers of America) Compounded Topical Drug Revenue and Gross Margin (2021-2026)
  35. 8.6.4 PCCA (Professional Compounding Centers of America) Compounded Topical Drug Product Portfolio
  36. 8.6.5 PCCA (Professional Compounding Centers of America) Recent Developments
  37. 8.7 Nephron Pharmaceuticals Corporation
  38. 8.7.1 Nephron Pharmaceuticals Corporation Company Information
  39. 8.7.2 Nephron Pharmaceuticals Corporation Business Overview
  40. 8.7.3 Nephron Pharmaceuticals Corporation Compounded Topical Drug Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Nephron Pharmaceuticals Corporation Compounded Topical Drug Product Portfolio
  42. 8.7.5 Nephron Pharmaceuticals Corporation Recent Developments
  43. 8.8 Medisca
  44. 8.8.1 Medisca Company Information
  45. 8.8.2 Medisca Business Overview
  46. 8.8.3 Medisca Compounded Topical Drug Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Medisca Compounded Topical Drug Product Portfolio
  48. 8.8.5 Medisca Recent Developments
  49. 8.9 Lorraine’s Pharmacy
  50. 8.9.1 Lorraine’s Pharmacy Company Information
  51. 8.9.2 Lorraine’s Pharmacy Business Overview
  52. 8.9.3 Lorraine’s Pharmacy Compounded Topical Drug Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Lorraine’s Pharmacy Compounded Topical Drug Product Portfolio
  54. 8.9.5 Lorraine’s Pharmacy Recent Developments
  55. 8.10 Institutional Pharmacy Solutions
  56. 8.10.1 Institutional Pharmacy Solutions Company Information
  57. 8.10.2 Institutional Pharmacy Solutions Business Overview
  58. 8.10.3 Institutional Pharmacy Solutions Compounded Topical Drug Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Institutional Pharmacy Solutions Compounded Topical Drug Product Portfolio
  60. 8.10.5 Institutional Pharmacy Solutions Recent Developments
  61. 8.11 Fresenius Kabi
  62. 8.11.1 Fresenius Kabi Company Information
  63. 8.11.2 Fresenius Kabi Business Overview
  64. 8.11.3 Fresenius Kabi Compounded Topical Drug Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Fresenius Kabi Compounded Topical Drug Product Portfolio
  66. 8.11.5 Fresenius Kabi Recent Developments
  67. 8.12 Fagron
  68. 8.12.1 Fagron Company Information
  69. 8.12.2 Fagron Business Overview
  70. 8.12.3 Fagron Compounded Topical Drug Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Fagron Compounded Topical Drug Product Portfolio
  72. 8.12.5 Fagron Recent Developments
  73. 8.13 Custom Scripts Pharmacy
  74. 8.13.1 Custom Scripts Pharmacy Company Information
  75. 8.13.2 Custom Scripts Pharmacy Business Overview
  76. 8.13.3 Custom Scripts Pharmacy Compounded Topical Drug Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Custom Scripts Pharmacy Compounded Topical Drug Product Portfolio
  78. 8.13.5 Custom Scripts Pharmacy Recent Developments
  79. 8.14 Central Admixture Pharmacy Services (CAPS)
  80. 8.14.1 Central Admixture Pharmacy Services (CAPS) Company Information
  81. 8.14.2 Central Admixture Pharmacy Services (CAPS) Business Overview
  82. 8.14.3 Central Admixture Pharmacy Services (CAPS) Compounded Topical Drug Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Central Admixture Pharmacy Services (CAPS) Compounded Topical Drug Product Portfolio
  84. 8.14.5 Central Admixture Pharmacy Services (CAPS) Recent Developments
  85. 8.15 CareFirst Specialty Pharmacy
  86. 8.15.1 CareFirst Specialty Pharmacy Company Information
  87. 8.15.2 CareFirst Specialty Pharmacy Business Overview
  88. 8.15.3 CareFirst Specialty Pharmacy Compounded Topical Drug Revenue and Gross Margin (2021-2026)
  89. 8.15.4 CareFirst Specialty Pharmacy Compounded Topical Drug Product Portfolio
  90. 8.15.5 CareFirst Specialty Pharmacy Recent Developments
  91. 8.16 Cantrell Drug Company
  92. 8.16.1 Cantrell Drug Company Company Information
  93. 8.16.2 Cantrell Drug Company Business Overview
  94. 8.16.3 Cantrell Drug Company Compounded Topical Drug Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Cantrell Drug Company Compounded Topical Drug Product Portfolio
  96. 8.16.5 Cantrell Drug Company Recent Developments
  97. 8.17 B. Braun Melsungen AG Company
  98. 8.17.1 B. Braun Melsungen AG Company Company Information
  99. 8.17.2 B. Braun Melsungen AG Company Business Overview
  100. 8.17.3 B. Braun Melsungen AG Company Compounded Topical Drug Revenue and Gross Margin (2021-2026)
  101. 8.17.4 B. Braun Melsungen AG Company Compounded Topical Drug Product Portfolio
  102. 8.17.5 B. Braun Melsungen AG Company Recent Developments
  103. 8.18 Avella Specialty Pharmacy
  104. 8.18.1 Avella Specialty Pharmacy Company Information
  105. 8.18.2 Avella Specialty Pharmacy Business Overview
  106. 8.18.3 Avella Specialty Pharmacy Compounded Topical Drug Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Avella Specialty Pharmacy Compounded Topical Drug Product Portfolio
  108. 8.18.5 Avella Specialty Pharmacy Recent Developments
  109. 8.19 Atlas Pharmaceuticals
  110. 8.19.1 Atlas Pharmaceuticals Company Information
  111. 8.19.2 Atlas Pharmaceuticals Business Overview
  112. 8.19.3 Atlas Pharmaceuticals Compounded Topical Drug Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Atlas Pharmaceuticals Compounded Topical Drug Product Portfolio
  114. 8.19.5 Atlas Pharmaceuticals Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst